Breast Cancer
Conditions
Keywords
Tomosynthesis,sensitivity,specificity,screening,mammography
Brief summary
Randomized trial comparing the performance of tomosynthesis and 2D Digital Mammography vs 2D Digital Mammography only in respect to incidence of advanced cancers (interval and following round) and interval cancers.
Detailed description
The investigators conduct a randomized trial (about 20000 tests in the intervention arm) comparing the performance of tomosynthesis plus 2D Digital Mammography vs usual care (2D digital mammography) in respect to incidence of advanced cancers (interval and following round) and interval cancers. The investigators also will measure detection rates, specificity, interval cancers, advanced cancers occurring as interval cancers or at subsequent screens and allowing to estimate overdiagnosis. In Reggio Emilia a population-based screening program is active. It invites all women from 45 to 74 years old for a 2D digital mammography (2 projections, double reading) every 2 years (annually from 45 to 49). Women will be asked for informed consent when they attend the mammography. I they accept they will be randomised to one of the two arms. All examinations will be read by two independent radiologists, in case of discordance a third reading is asked.
Interventions
twice screening examination: standard 2D mammography + Digital Breast Tomosynthesis
Sponsors
Regione Emilia-Romagna
Azienda USL Reggio Emilia - IRCCS
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Eligibility
Sex/Gender
FEMALE
Age
45 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
45-70 years old women invited to breast cancer screening program who accepted to participate
Exclusion criteria
* previous breast cancer diagnosis * pregnancy or suspicion of pregnancy * presence of BRCA1/2 gene mutation * Previous Digital Breast Tomosynthesis performed * unable to understand informed consent * chemotherapy in progress * presence of breast implant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cumulative incidence of T2+ cancers after screening | 2 years |
| incidence of interval cancers | 2 years |
Secondary
| Measure | Time frame |
|---|---|
| Positive Predictive value | baseline |
| diagnostic agreement between tomosynthesis and 2d mammography | baseline |
| Detection rate of in situ ductal carcinoma | 2 years |
| Detection rate | 2 years |
| self-reported pain and discomfort during mammography | baseline |
| x-ray dose | baseline |
| biopsy rate | baseline |
| recall rate | baseline |
Countries
Italy
Outcome results
None listed